[Bevacizumab treatment for acquired vitelliform detachment in patient with cuticular drusen]. / Desprendimiento viteliforme adquirido en paciente con drusas cuticulares tratado con bevacizumab.
Arch Soc Esp Oftalmol
; 89(4): 165-9, 2014 Apr.
Article
em Es
| MEDLINE
| ID: mdl-24269467
ABSTRACT
CASE REPORT We report a case of a 30-year-old male with acquired vitelliform detachment (AVD) secondary to cuticular drusen and suffering from metamorphopsia in his right eye. Intravitreal bevacizumab (Avastin) was administered, achieving successful results. DISCUSSION:
An independent disease, of unknown genetic phenotype, caused by a generalized dysfunction of the retinal pigment epithelium (RPE). About 50% of patients develop AVD, and a correct diagnosis can be made with the help of new complementary tests. With no effective treatment currently available, and because of the incidence of developing choroidal neovascularization (NVC), treatment with anti-VEGF could help stabilize or improve the disease functionally and/or anatomically.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Descolamento Retiniano
/
Oftalmopatias Hereditárias
/
Drusas Retinianas
/
Lâmina Basilar da Corioide
/
Neovascularização de Coroide
/
Inibidores da Angiogênese
/
Bevacizumab
Idioma:
Es
Ano de publicação:
2014
Tipo de documento:
Article